Description
IGF::CT::IGF VISN 23 COAGULATION BPA
First action · last action
2013-10-01 · 2014-07-24
Transactions
2
First transaction's obligation
$28,560
Base + all options value (sum of deltas)
$9,156
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
4
SDVOSB flag on record
No
Parent IDV
VA263BP0125
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-01+$28,560= $28,560
- Mod P000012014-07-24-$19,403= $9,156
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-01 | +$28,560 | $28,560 | IGF::CT::IGF VISN 23 COAGULATION BPA |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-07-24 | −$19,403 | $9,156 | IGF::CT::IGF VISN 23 COAGULATION BPA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under W065 from 656-ST CLOUD VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26314J1461 | ORTHO-CLINICAL DIAGNOSTICS, INC | 656-ST CLOUD VA MEDICAL CENTER | $105,102 | FY2015 |
| VA26314J1310 | ORTHO-CLINICAL DIAGNOSTICS, INC | 656-ST CLOUD VA MEDICAL CENTER | $733,065 | FY2015 |
| VA26314J1368 | ORTHO-CLINICAL DIAGNOSTICS, INC | 656-ST CLOUD VA MEDICAL CENTER | $70,185 | FY2015 |
| VA26314J6035 | ORTHO-CLINICAL DIAGNOSTICS, INC | 656-ST CLOUD VA MEDICAL CENTER | $618,484 | FY2014 |
| VA26314J6046 | ORTHO-CLINICAL DIAGNOSTICS, INC | 656-ST CLOUD VA MEDICAL CENTER | $615,395 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26314J6044_3600_VA263BP0125_3600 · retrieved 2026-09-26.